- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
Novocure Ltd. Aktie
Verkaufen
Kaufen
Novocure Ltd. Chart
Novocure Ltd. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,99 %
Intraday
-1,73 %
1 Woche
-18,25 %
1 Monat
-25,87 %
Seit Jahresbeginn
45,14 %
1 Jahr
-69,72 %
3 Jahre
-74,97 %
5 Jahre
Wikifolio
Passender Service zu Novocure Ltd.
Webinar zu Novocure Ltd.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)11,700-34,130
- Jahrestief / Hoch ($)20,715-31,170
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Novocure Ltd.
Keine Dividenden verfügbar
Termine von Novocure Ltd.
- Feb27Novocure Ltd.Q4 2024 Earnings Release
- Mai1Novocure Ltd.Q1 2025 Earnings Release
- Jul24Novocure Ltd.Q2 2025 Earnings Release
Beschreibung
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
